Want to see HK:3347 full AI Analyst Report?
Hangzhou Tigermed Consulting Co., Ltd. Class H (3347) Financial Statements
4 Followers
Hangzhou Tigermed Consulting Co., Ltd. Class H Financial Overview
Hangzhou Tigermed Consulting Co., Ltd. Class H's market cap is currently ¥42.72B. The company's EPS TTM is ¥-0.47; its P/E ratio is -112.23; and it has a dividend yield of 0.36%. Hangzhou Tigermed Consulting Co., Ltd. Class H is estimated to report earnings on March 29, 2027, and the estimated EPS forecast is ¥0.54. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 6.83B | ¥ 6.60B | ¥ 7.38B | ¥ 7.09B | ¥ 5.21B |
| Gross Profit | ¥ 1.87B | ¥ 2.24B | ¥ 2.85B | ¥ 2.81B | ¥ 2.27B |
| Operating Income | ¥ 1.01B | ¥ 664.42M | ¥ 2.49B | ¥ 2.58B | ¥ 1.92B |
| EBITDA | ¥ 1.42B | ¥ 1.13B | ¥ 2.91B | ¥ 2.93B | ¥ 3.90B |
| Net Income | ¥ 887.89M | ¥ 405.14M | ¥ 2.02B | ¥ 2.01B | ¥ 2.87B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 1.84B | ¥ 2.13B | ¥ 7.46B | ¥ 7.88B | ¥ 8.57B |
| Total Assets | ¥ 28.36B | ¥ 28.67B | ¥ 29.68B | ¥ 27.45B | ¥ 23.74B |
| Total Debt | ¥ 1.47B | ¥ 2.63B | ¥ 2.83B | ¥ 2.80B | ¥ 1.19B |
| Net Debt | ¥ -302.82M | ¥ 579.64M | ¥ -4.59B | ¥ -5.06B | ¥ -7.35B |
| Total Liabilities | ¥ 4.10B | ¥ 4.61B | ¥ 5.23B | ¥ 4.77B | ¥ 3.14B |
| Stockholders' Equity | ¥ 20.96B | ¥ 20.67B | ¥ 21.03B | ¥ 19.58B | ¥ 18.12B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 903.72M | ¥ 740.45M | ¥ 836.68M | ¥ 908.90M | ¥ 1.06B |
| Operating Cash Flow | ¥ 1.12B | ¥ 1.10B | ¥ 1.15B | ¥ 1.36B | ¥ 1.42B |
| Investing Cash Flow | ¥ 491.56M | ¥ -4.74B | ¥ -1.53B | ¥ -2.79B | ¥ -2.78B |
| Financing Cash Flow | ¥ -1.93B | ¥ -1.70B | ¥ -7.81M | ¥ 809.25M | ¥ -163.09M |
Currency in CNY
